Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.6550
-0.0150
(-2.24%)
At close: February 28 at 2:05:34 PM GMT+1
Key Executives
Key Executives Information Not Available
Vidac Pharma Holding Plc
Description
Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases. The company is developing VDA-1102 ointment, an anti-neoplastic agent that is in Phase 2 clinical trials for triggering apoptosis in cancer cells with minimal effects on surrounding normal cells. It is also developing VDA-1102 IV, an anti-neoplastic agent; and VDA-1275, a potent small molecule new chemical entity that are in preclinical stage for use in the treatment of solid tumors. The company was incorporated in 2021 and is based in London, the United Kingdom.
Corporate Governance
Vidac Pharma Holding Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
BIOV.SW BioVersys AG
35.38
+0.23%
MOLN Molecular Partners AG
5.03
+10.07%
BSLN.SW Basilea Pharmaceutica AG
47.15
+2.06%
NRSN NeuroSense Therapeutics Ltd.
1.1075
+3.50%
SANN.SW Santhera Pharmaceuticals Holding AG
16.26
-1.45%
ADXN Addex Therapeutics Ltd
8.50
+0.59%
BCDA BioCardia, Inc.
2.0100
-1.47%
THTX Theratechnologies Inc.
1.6500
+1.85%
NLSP NLS Pharmaceutics AG
1.8400
+1.10%
ANIX Anixa Biosciences, Inc.
3.1500
+2.61%